ArticleCancer immunology, immunotherapy : CII2024

Allogeneic CAR-T cells with of HLA-A/B and TRAC disruption exhibit promising antitumor capacity against B cell malignancies.

Xinfeng Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.